March 22, 2018 - OrthoBuzz

Giant-Cell Tumor Treatment: Curettage Without Denosumab Is Better

March 22, 2018March 28, 2018 OrthoBuzz for Surgeons

Denosumab is an FDA-approved drug for osteoporosis. It works by binding RANKL, thus inhibiting osteoclastic activity. Denosumab has also been shown to have a favorable

Day: March 22, 2018

Giant-Cell Tumor Treatment: Curettage Without Denosumab Is Better